Malaria vaccine - BioSante/Naval Medical Research Center
Latest Information Update: 02 Oct 2021
At a glance
- Originator BioSante Pharmaceuticals; Naval Medical Research Center
- Developer ANI Pharmaceuticals; Naval Medical Research Center
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 19 Jul 2005 Phase-I/II clinical trials in Malaria prevention in USA (unspecified route)
- 14 Feb 2003 Preclinical trials in Malaria prevention in USA (unspecified route)